$1145.03
00.00%
Pre-Market: Sep 20, 4:39 PM EDT
15 minutes delayed
Regeneron Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Regeneron Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $11.56 | $10.53 | 9.78 % |
Mar 2024 | 2024-05-02 | $9.55 | $10.10 | -5.45 % |
Dec 2023 | 2024-02-02 | $11.86 | $10.77 | 10.1 % |
Sep 2023 | 2023-11-02 | $11.59 | $10.77 | 7.61 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $3.55B | $3.36B | 5.57 % |
Mar 2024 | 2024-05-02 | $3.15B | $3.22B | -2.33 % |
Dec 2023 | 2024-02-02 | $3.43B | $3.29B | 4.38 % |
Sep 2023 | 2023-11-02 | $3.36B | $3.22B | 4.44 % |
Regeneron Pharmaceuticals (REGN) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $11.56, which beat the estimate of $10.53.
The Actual Revenue was $3.5B, which beat the estimate of $3.4B.
Browse earnings estimates, EPS, and revenue on all stocks.